About this source
- Kind
- Research
- Design
- Meta-analysis, RCT, Systematic review
- Population
- Adults with severe acute pancreatitis, 5 pooled randomised controlled trials
- Sample size
- 706
- Primary or secondary
- secondary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 13 August 2026
Limitations
Relatively few pooled studies; substantial dosing heterogeneity; authors themselves describe mortality and adverse-event outcome measures as insufficient to draw firm conclusions; mixed-language evidence base (3 of 5 trials Chinese-language).
Cited in
Severe acute pancreatitis trials
Thymosin Alpha-1 · Research finding
ModerateAuthors state safety data insufficient
Thymosin Alpha-1 · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.